Cure Thalassemia - Company Profile

It is a healthcare private not for profit company based in Hyderabad, Telangana, India, established in 2011.
2011 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Cure Thalassemia

Cure Thalassemia, a active private not for profit company, was established on 21 July 2011 in Hyderabad, Telangana, India. Engaging in other hospital and medical care activities within the healthcare sector, it holds CIN: U85100TG2011NPL075631. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Mahesh Kumar Agarwal (Director), Chandrakant Agrawal (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 21-1-686, Rikab Gunj, Hyderabad, Telangana, 500002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100TG2011NPL075631

  • Registration Number

    075631

  • Incorporation Date

    21 July 2011

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth -1.73%
  • Total Assets -0.27%
Company report

Cure Thalassemia

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cure Thalassemia — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Cure Thalassemia?
Current Directors
Name Designation Appointment Date Status
Mahesh Kumar Agarwal Director 21 Jul 2011 Current
Chandrakant Agrawal Director 21 Jul 2011 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cure Thalassemia.

Cure Thalassemia, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.73%.

Cure Thalassemia revenue growth over time
Cure Thalassemia profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.27%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 -1.73%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cure Thalassemia?

In 2017, Cure Thalassemia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cure Thalassemia?

Unlock and access historical data on people associated with Cure Thalassemia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cure Thalassemia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure Thalassemia's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cure Thalassemia
Recent Activity within the Organization
  • Annual General Meeting

    The activity Cure Thalassemia last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Cure Thalassemia has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    The activity Mahesh Kumar Agarwal was appointed as a Director was appointed as a Director on 21 Jul 2011 & has been associated with this company since 14 years 6 months . was completed.

  • Director Appointment

    Progress on Chandrakant Agrawal was appointed as a Director was appointed as a Director on 21 Jul 2011 & has been associated with this company since 14 years 6 months . was documented.

  • Company Incorporation

    Progress on Cure Thalassemia was registered on 21 Jul 2011 with Roc Hyderabad & aged 14 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cure Thalassemia?

The CIN of Cure Thalassemia is U85100TG2011NPL075631.

Where is Cure Thalassemia headquartered?

Cure Thalassemia is headquartered at 21-1-686, Rikab Gunj, Hyderabad, Telangana, 500002.

When was Cure Thalassemia incorporated?

Cure Thalassemia was incorporated on 21 July 2011.

Who are the current directors of Cure Thalassemia?

The current directors of Cure Thalassemia are

What is the primary industry of Cure Thalassemia?

The primary industry of Cure Thalassemia is Healthcare.

Is Cure Thalassemia a listed company?

Cure Thalassemia is unlisted.

What is the capital structure of Cure Thalassemia?

The authorized capital of Cure Thalassemia is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Cure Thalassemia?

The compliance status of Cure Thalassemia is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available